Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × apalutamide × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 26 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1

Interventions

pembrolizumab 26 Cyclophosphamide 19 Nivolumab 15 Doxorubicin 12 Radiotherapy 9 Exercise 9 Carboplatin 9 atezolizumab 8 Surveys and Questionnaires 8 Rituximab 8 Prednisone 8 Paclitaxel 8 Docetaxel 8 Dexamethasone 8 Bevacizumab 8 venetoclax 7 fludarabine 7 budigalimab 7 Vincristine 7 Fluorouracil 7 Blood Specimen Collection 7 lenvatinib 6 dostarlimab 6 cemiplimab 6 Pemetrexed 6 Oxaliplatin 6 Cisplatin 6 Cetuximab 6 durvalumab 5 cabozantinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04295447 2024-06-20

ADAM

Universität Münster

Phase 2 Active not recruiting

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡